| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
1 Laboratory of Molecular Growth Regulation, National Institute of Health, Bethesda, MD;
2 Department of Molecular Biology, Pusan National University, Busan, Republic of Korea;
3 Department of Biochemistry, College of Oriental Medicine, Dong-Eui University, Busan, Republic of Korea;
4 Department of Biology, Kyungpook National University, DaeGu, Republic of Korea; and
5 Department of Medicine/Endocrinology, Baylor College of Medicine Houston, TX
Requests for reprints: JaeHun Cheong, Department of Molecular Biology, Pusan National University, Busan 609-735, Republic of Korea. Phone: 82-51-510-2277; Fax: 82-51-513-9258. E-mail: molecule85{at}pusan.ac.kr
Activating signal cointegrator-2 (ASC-2), a novel coactivator, is amplified in several cancer cells and known to interact with mitogenic transcription factors, including serum response factor, activating protein-1, and nuclear factor-
B, suggesting the physiological role of ASC-2 in the promotion of cell proliferation. Here, we show that the expression pattern of ASC-2 was correlated with that of E2F-1 for protein increases at G1 and S phase. Furthermore, cells stably overexpressing ASC-2 had an increased cell proliferation profile. These results prompted us to examine the functional interaction of ASC-2 and E2F-1. Biochemical evidence of protein interaction indicated that the transactivation domain of E2F-1 interacted with the COOH-terminal region of ASC-2. The importance of the E2F-1-ASC-2 interaction was supported by the demonstration that the coexpression of ASC-2 and E2F-1 synergistically transactivated E2F-1-driven gene transcription and the acetylation of E2F-1 protein was necessary for ASC-2-mediated transcriptional coactivation. Interestingly, overexpression of ASC-2 increased the endogenous protein level of E2F-1 in cells, resulting from the prolonged protein stability of E2F-1. Taken together, these results suggest that the cancer-amplified transcriptional coactivator ASC-2 may promote cell proliferation through enhancement of E2F-1-dependent transactivation of the expression of genes associated with cell cycle progression that may be available to favor tumor growth in vivo.
This article has been cited by other articles:
![]() |
S.-Y. Yeom, G. H. Kim, C. H. Kim, H. D. Jung, S.-Y. Kim, J.-Y. Park, Y. K. Pak, D.-K. Rhee, S.-Q. Kuang, J. Xu, et al. Regulation of Insulin Secretion and {beta}-Cell Mass by Activating Signal Cointegrator 2 Mol. Cell. Biol., June 15, 2006; 26(12): 4553 - 4563. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Mahajan and H. H. Samuels Nuclear Hormone Receptor Coregulator: Role in Hormone Action, Metabolism, Growth, and Development Endocr. Rev., June 1, 2005; 26(4): 583 - 597. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Zhang, S.-Q. Kuang, L. Liao, S. Zhou, and J. Xu Haploid Inactivation of the Amplified-in-Breast Cancer 3 Coactivator Reduces the Inhibitory Effect of Peroxisome Proliferator-Activated Receptor {gamma} and Retinoid X Receptor on Cell Proliferation and Accelerates Polyoma Middle-T Antigen-Induced Mammary Tumorigenesis in Mice Cancer Res., October 1, 2004; 64(19): 7169 - 7177. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. V. Frolov and N. J. Dyson Molecular mechanisms of E2F-dependent activation and pRB-mediated repression J. Cell Sci., May 1, 2004; 117(11): 2173 - 2181. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |